Emmanuel Baetge

ViaCyte, Inc.

Awards as PI

Funding
Disease Team Planning Development of a Cell Replacement Therapy Product for Insulin Dependent Diabetes $48,950
Total:
$48,950.00

© 2013 California Institute for Regenerative Medicine